LakeShore Biopharma Co., Ltd

LSB · NASDAQ
Analyze with AI
3/31/2025
3/31/2024
3/31/2023
3/31/2022
Assets
Cash & Equivalents$28,084$246,351$370,108$271,068
Short-Term Investments$0$0$0$0
Receivables$501,790$444,161$468,203$308,555
Inventory$227,592$203,423$185,381$166,506
Other Curr. Assets$84,752$9,233$12,287$18,636
Total Curr. Assets$842,218$903,168$1,035,979$764,764
Property Plant & Equip (Net)$414,349$480,623$582,889$565,003
Goodwill$0$0$0$0
Intangibles$72,855$71,245$78,057$80,718
Long-Term Investments$0$0$0$200,007
Tax Assets$27,947$23,634$1,906$3,039
Other NC Assets$10,295$34,357$20,924-$648,760
Total NC Assets$525,445$609,859$683,775$200,007
Other Assets$0$0$0$0
Total Assets$1,367,663$1,513,027$1,719,754$201,034
Liabilities
Payables$49,552$67,775$80,439$30,811
Short-Term Debt$390,897$323,697$198,490$116,056
Tax Payable$2,800$3,013$380$1,171
Deferred Revenue$1,456$2,016$2,296$2,296
Other Curr. Liab.$380,048$405,725$377,157-$150,192
Total Curr. Liab.$824,753$802,226$658,762$143
LT Debt$23,503$100,767$300,139$264,533
Deferred Rev, NC$16,208$20,280$23,607$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$3,445$4,548$8,792$30,054
Total NC Liab.$43,156$125,595$332,538$294,587
Other Liabilities$0$0$0$0
Cap. Leases$457$6,940$11,102$14,928
Total Liabilities$867,909$927,821$991,300$20,352
Equity
Pref Stock$0$0$0$1,370,221
Common Stock$29$26$12$8
Retained Earnings-$2,407,485-$2,307,503-$1,874,038-$1,590,567
AOCI-$57,272-$58,180-$54,412$83,088
Other Equity$2,964,483$2,950,863$2,656,891$808,502
Total Equity$499,755$585,206$728,453$671,252
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$1,367,663$1,513,027$1,719,754$201,034
Net Debt$386,317$178,113$128,522$109,522